Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) Is Looking Good Over The Long Term, Gained Nearly 19.05% Over A Month.

In last trading session, Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) saw 2.44 million shares changing hands with its beta currently measuring -0.06. Company’s recent per share price level of $1.50 trading at $0.07 or 4.53% at ring of the bell on the day assigns it a market valuation of $51.87M. That closing price of RVPH’s stock is at a discount of -278.0% from its 52-week high price of $5.67 and is indicating a premium of 60.0% from its 52-week low price of $0.60. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 8.26 million shares which gives us an average trading volume of 1.67 million if we extend that period to 3-months.

For Reviva Pharmaceuticals Holdings Inc (RVPH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.50. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.22 in the current quarter.

Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) trade information

Upright in the green during last session for gaining 4.53%, in the last five days RVPH remained trading in the red while hitting it’s week-highest on Friday, 12/13/24 when the stock touched $1.50 price level, adding 49.15% to its value on the day. Reviva Pharmaceuticals Holdings Inc’s shares saw a change of -70.87% in year-to-date performance and have moved -45.85% in past 5-day. Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) showed a performance of 19.05% in past 30-days. Number of shares sold short was 5.3 million shares which calculate 19.04 days to cover the short interests.

Reviva Pharmaceuticals Holdings Inc (RVPH) estimates and forecasts

Statistics highlight that Reviva Pharmaceuticals Holdings Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 20.00% of value to its shares in past 6 months, showing an annual growth rate of 38.79% while that of industry is 16.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s Major holders

Insiders are in possession of 14.79% of company’s total shares while institution are holding 30.07 percent of that, with stock having share float percentage of 35.28%. Investors also watch the number of corporate investors in a company very closely, which is 30.07% institutions for Reviva Pharmaceuticals Holdings Inc that are currently holding shares of the company. WOODLINE PARTNERS LP is the top institutional holder at RVPH for having 1.59 million shares of worth $2.04 million. And as of 2024-06-30, it was holding 6.6273 of the company’s outstanding shares.

The second largest institutional holder is MILLENNIUM MANAGEMENT LLC, which was holding about 1.24 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.1656 of outstanding shares, having a total worth of $1.59 million.